QSA's Week in BioPharma (#11, 2025)
Canada invests $60M in Boucherville biomanufacturing; $5M in Nova Scotia bio-innovation; $49.9M in STEMCELL Technologies.

Good morning! Welcome back to Queen Street Analytics' weekly roundup of regulatory developments, legislative discussions, political announcements and other government-related news in biotech, pharmaceutical manufacturing, drug distribution and pricing, the life sciences and medical research.
Every Monday, we break down the most important updates in this space in under five minutes.
Join our thousands of subscribers. Sign up here!
Start Date: 2025-03-16
End Date: 2025-03-22
Top Headlines
Main Stories
Canada's $60 Million Biomanufacturing Boost in Boucherville
The Canadian government announced a $60 million investment in Delpharm Boucherville Canada Inc. to enhance its biomanufacturing capacity. This project, supported by the Strategic Innovation Fund, aims to double the facility's production of sterile injectables to 130 million units annually. The expansion will create 450 permanent jobs and 150 student co-op positions, boosting Canada's domestic production capabilities for essential medicines.
Sources: Announcements: www.canada.ca
Nova Scotia's Bio-Innovation Hub Receives $5 Million
The Government of Canada is investing $5 million in Neptune BioInnovation Inc. to establish a bio-innovation hub in Dartmouth, Nova Scotia. This initiative will transform an underutilized facility into a space for biomanufacturing and precision fermentation, supporting local and global biotechnology advancements. The project aims to strengthen domestic supply chains and enhance Canada's position in the life sciences sector.
Sources: Announcements: www.canada.ca